PT - JOURNAL ARTICLE AU - Liu, Bin AU - Liu, Yu AU - Li, Zhiqian AU - Xiao, Jianghong AU - Yin, Guosheng AU - Lin, Huazhen TI - Automatic radiotherapy treatment planning with deep functional reinforcement learning AID - 10.1101/2024.06.23.24309060 DP - 2024 Jan 01 TA - medRxiv PG - 2024.06.23.24309060 4099 - http://medrxiv.org/content/early/2024/10/04/2024.06.23.24309060.short 4100 - http://medrxiv.org/content/early/2024/10/04/2024.06.23.24309060.full AB - Background and purpose Intensity-modulated radiation therapy (IMRT) is a crucial radiotherapy technique, often formulated as an optimization problem. However, when the constraints are too tight to provide a feasible solution, human planners resort to relaxing the optimization parameters and re-evaluating until an acceptable solution is obtained. This process is laborious and time-consuming which has prompted attempts to automate radiotherapy through inverse planning studies using reinforcement learning. Unfortunately, these studies face two major limitations. Firstly, a separate sub-network must be designed for each organ, rendering them difficult to apply to patients with an inconsistent number of structures. Secondly, the low signal-to-noise inputs and discrete action space result in low training efficiency. To address these limitations, this study proposes a novel and effective model.Methods This study proposes an organ-sharing network called Functional automatic treatment PlannI ng Network (FatPIN), which contains a functional embedding layer to extract curve features of the dose-volume histogram (DVH). It outputs continuous actions that adjust the optimization parameters, thereby automating the radiotherapy planning process.Results Experiments were conducted on the cervical cancer dataset and the results show that the FatPIN is feasible and effective in real-world radiotherapy. With automatic iteration, FatPIN gradually increased the PTV dose, while reducing the dose levels of the OARs. Specifically, at step 50, the D95 of the PTV reached 51.68 Gy, exceeding the clinical standard of 50.40 Gy, the V30, V40 and V50 of all OARs were within clinical requirements.Conclusion We proposed FatPIN to implement automatic radiotherapy treatment planning. Experimental assessments conducted on cases of cervical cancer demonstrate significant improvements in patient metrics facilitated by FatPIN, thus confirming its practical applicability in clinical contexts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this study was obtained from Biomedical Ethics Review Committee of West China Hospital of Sichuan University, China with relevant Chinese laws, regulations and rules (Measures for Ethical Review of Biomedical Research Involving Human Beings, etc.) as well as the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approval was sought for the present study by the Biomedical Ethics Review Committee of West China Hospital of Sichuan University, China.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors